$129.00
Diagnosis of congenital or acquired Antithrombin deficiencies. Measurement of ATIII activity in biological milieu or purified fractions.
PRODUCT DESCRIPTION
In EU: This Product is CE Marked. Health Canada Licensed. Chromogenic assay for the measurement of antithrombin (AT) activity in human plasma, with an anti-Xa method. Automatic or Manual method.
Diagnosis of congenital or acquired Antithrombin deficiencies. Measurement of ATIII activity in biological milieu or purified fractions.
PRODUCT CHARACTERISTICS
Total Assay Time: < 3 min Detection Threshold: ≤ 5% Dynamic Range: 0 to 100% Intra-Assay CV: < 3% Inter-Assay CV: < 5% No known drug interference in the assay. No interference of Heparin Cofactor II, α2-macroglobulin or α1-Antitrypsin. No interference of Heparin Cofactor II, α2-macroglobulin or α1-Antitrypsin. No interference for hemoglobin concentrations up to 5 mg/mL, for Bilirubin concentrations up to 0.1 mg/mL, and for plasma from hyperlipaemic patients.
PRODUCT COMPONENTS
R1: 2 x 2.5 mL Bovine Factor Xa.
R2: 2 x 2.5 mL Chromogenic substrate, specific for Factor Xa (SXa-11).
R3: 2 x 5 mL of Tris-Heparin Buffer.
Video of Product Components
PRODUCT APPLICATION
Diagnosis of congenital or acquired Antithrombin deficiencies.
MSDS Documents
IFU Documents
